Supply of Medicines and Drugs on Bulk Purchase to Aiwan-e-Sadr Dispensary FY 2026-27

The President's Secretariat (Personal) invites sealed bids from qualified firms, vendors and suppliers for the supply of medicines and drugs on bulk purchase to Aiwan-e-Sadr Dispensary for the financial year 2026-27. This is a bulk pharmaceutical procurement contract for a federal government medical facility in Islamabad. Detailed specifications and tentative quantities are provided in Annexure-A and Annexure-B of the tender document. The procurement will follow single-stage two-envelope evaluation procedure as per Public Procurement Regulatory Authority (PPRA) rules and regulations.

Bidders must be reputable firms with good market standing and valid registration as per the checklist requirements outlined in Appendix-B. Each bidder is required to submit 5% of the quoted bid amount as bid security in the form of a bank draft or pay order made in favour of the Assistant Secretary (Accounts), President's Secretariat (Personal). All applicable federal, provincial and local taxes and duties must be included in the quoted price, which should be final and unambiguous. A 10% performance guarantee will be required from the successful bidder upon award of contract.

Tender documents in hard copy may be obtained 24/7 from the Dak Inquiry Window at President's Secretariat (Personal), Aiwan-e-Sadr, Islamabad. Bidders must prepare and collect all required documents as listed in the checklist, spiral-bind them, and seal the technical and financial proposals in envelopes provided by the Secretariat. A pre-bid conference will be held three days before tender opening. The tender will be opened in 2026 as per PPRA rules. Contact the Assistant Secretary (Administration) at phone 9206065 for further information.

This is a bulk medicines and drugs supply contract for a federal presidential facility in Islamabad for the full financial year 2026-27. Quantities are described as tentative and may vary with actual organizational requirement, suggesting this could be recurring or framework-based. The procurement uses PPRA-compliant two-envelope evaluation and requires 5% bid security upfront. Pharmaceutical suppliers with federal government registration and market reputation are the primary target. No estimated contract value is disclosed in the notice.

Who can bid: Bidders must have good market reputation and valid registration per the checklist (Appendix-B). Pharmaceutical suppliers typically require Drug Regulatory Authority (DRA) registration, relevant business licenses, and either SECP registration (private firms) or provincial authorization. The notice excludes any firm under existing litigation with Aiwan-e-Sadr Dispensary.